Expecto Health Science

Expecto Health Science

Biotechnology Research

Trusted Partner in Drug Development

About us

Expecto Health Science, a leading Clinical Research Organization headquartered in Singapore, specializes in delivering comprehensive and cost-effective services throughout the Asia Pacific Region. Our expertise encompasses Clinical Development, Data Management, Medical Writing, Regulatory, and Pharmacovigilance, offering tailored solutions for our clients. We pride ourselves on our tailored FSP (Functional Service Provider) solutions, providing strategic resourcing options to regional and global Pharma clients in the most cost-efficient manner. Our client base spans from companies pioneering new chemical entities, biologicals in their early clinical development phases, to small/mid-sized pharmaceutical and biotechnology firms with niche products, and medical device companies.

Website
www.expectohealthscience.com
Industry
Biotechnology Research
Company size
11-50 employees
Headquarters
Singapore
Type
Privately Held
Founded
2023
Specialties
Healthcare, Medical Device , Biotechnology, Clinical Research, Preclinical and Toxicity , Medical Writing , Pharmacovigilance, and Cosmetics and Personal Care

Locations

Employees at Expecto Health Science

Updates

  • Expecto Health Science's director, Sachin Patil attended the 𝗣𝗵𝗮𝗿𝗺𝗮 𝗖𝗮𝗿𝗲𝗲𝗿 𝗖𝗼𝗻𝗳𝗹𝘂𝗲𝗻𝗰𝗲 𝟭.𝟬, a flagship event hosted by BVDU POONA COLLEGE OF PHARMACY. Featuring inspiring talks by distinguished speakers who shared their expertise and wisdom, the event created a valuable platform for industry-academia collaboration and shed light on the dynamic world of the pharmaceutical sector both in India and globally. Sachin Patil shared his insights on careers in the Clinical Research industry, the various opportunities and requirements associated with the industry and offered practical advice on bridging the gap between academic skills and industry needs, emphasizing a growth mindset for success in this competitive field. The Expert-led sessions offered actionable insights into pharmaceutical and healthcare trends and challenges, empowering BVDU Poona College of Pharmacy students to excel and contribute to the industry meaningfully. Expecto Health Science would like to thank BVDU Poona College of Pharmacy management as well as all the members of the student working committee and congratulate them on this successful event. #ClinicalResearch #Pharmacy #ClinicalDevelopment #PharmaIndustry #India #CareersInClinicalResearch #PharmaCareers #Academia Ashish Shirsat Rahul Somani Vivek Saoji Dr. Atmaram Pawar Dr. Varsha Pokharkar Dr. Sathiyanarayanan Lohidasan Vaibhav Shinde Santosh Kalawati Umakant Yele Akshay Khandke

    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
  • We are pleased to announce that our CEO, Dr. Pramod Kashid will be attending the scientific seminar organized by the 𝗜𝗻𝗱𝗼𝗻𝗲𝘀𝗶𝗮𝗻 𝗔𝘀𝘀𝗼𝗰𝗶𝗮𝘁𝗶𝗼𝗻 𝗳𝗼𝗿 𝘁𝗵𝗲 𝗦𝘁𝘂𝗱𝘆 𝗼𝗳 𝗠𝗲𝗱𝗶𝗰𝗶𝗻𝗮𝗹𝘀 (𝗜𝗔𝗦𝗠𝗘𝗗) in Jakarta, where Clinical Research Professionals, Principal Investigators, Key Opinion Leaders and Industry Experts will convene and provide valuable insights for the advancement of clinical trials in Indonesia. If you are planning to attend and would like to exchange ideas and discuss collaborations with Expecto Health Science, Dr Kashid would like to hear from you – please reach out to him on bd@expectohealthscience.com. #ClinicalTrials #Indonesia #ClinicalResearch #LifeSciences #Pharma #Biotech #Healthcare #PatientCentric #InnovativeTherapies #IASMED

    • No alternative text description for this image
  • 𝗪𝗲𝗮𝗿𝗮𝗯𝗹𝗲 𝗗𝗲𝘃𝗶𝗰𝗲𝘀 are revolutionizing clinical trials by enabling real-time patient monitoring, enhancing data accuracy, and improving trial efficiency. From smartwatches to sensors and smart glasses, these devices provide valuable insights into patient health, allowing researchers to make data-driven decisions and ultimately improve patient outcomes. 𝗧𝗵𝗲 𝗙𝘂𝘁𝘂𝗿𝗲 𝗼𝗳 𝗪𝗲𝗮𝗿𝗮𝗯𝗹𝗲 𝗗𝗲𝘃𝗶𝗰𝗲𝘀 𝗶𝗻 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗧𝗿𝗶𝗮𝗹𝘀  ▶️With advancements in AI and machine learning these will enhance data analysis ▶️As wearables evolve, they could offer more detailed insights, supporting advanced personalized medicine ▶️The growing prevalence of wearables in everyday life could speed up their adoption in clinical trials, giving researchers access to richer, more comprehensive data for improving treatment development Explore below some of the benefits and challenges of using wearables in clinical trials and learn more about fascinating wearables being used in trials. Which one do you find the most intriguing? Share your thoughts in the comments! Do you want to leverage wearables in clinical trials? Get in touch with us on bd@expectohealthscience.com to know more.

  • 🌟 𝗔𝗱𝘃𝗮𝗻𝗰𝗶𝗻𝗴 𝗗𝗶𝘃𝗲𝗿𝘀𝗶𝘁𝘆, 𝗘𝗾𝘂𝗶𝘁𝘆, 𝗮𝗻𝗱 𝗜𝗻𝗰𝗹𝘂𝘀𝗶𝗼𝗻 (𝗗𝗘𝗜) 𝗶𝗻 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗧𝗿𝗶𝗮𝗹𝘀 🌍 At Expecto Health Science, we are committed to embedding DEI principles into every phase of clinical research. Our approach is about going beyond compliance—it’s about creating a meaningful impact. 💡 By addressing barriers to participation, collaborating with community leaders, and leveraging innovative trial designs, we aim to make clinical trials accessible and inclusive for underrepresented populations. We are proud to work with sponsors and stakeholders who share this vision of inclusive research. Together, we aim to create clinical trials that are representative, equitable, and impactful. 🤝 Let’s move the needle toward health equity—one trial at a time. If you have innovative ideas to promote DEI in clinical research, let’s connect and collaborate! #DiversityInResearch #HealthEquity #ClinicalTrials #InclusionMatters #Diversity #Equity #Inclusion #Healthcare #ClinicalResearch

  • 𝗛𝗮𝗽𝗽𝘆 𝗡𝗲𝘄 𝗬𝗲𝗮𝗿 from all of us at Expecto Health Science! We’re so grateful for all our clients, partners, friends and colleagues. Thank you for your trust, your continued support, and the opportunity to work alongside such incredible individuals and organizations. Your collaboration has been instrumental to our success, and we look forward to continuing our journey together. 𝗪𝗲 𝗰𝗮𝗻'𝘁 𝘄𝗮𝗶𝘁 𝘁𝗼 𝗺𝗼𝘃𝗲 𝗼𝗻𝘄𝗮𝗿𝗱 𝗮𝗻𝗱 𝘂𝗽𝘄𝗮𝗿𝗱 𝗶𝗻 𝟮𝟬𝟮𝟱! 𝗪𝗶𝘀𝗵𝗶𝗻𝗴 𝘆𝗼𝘂 𝗮𝗹𝗹 𝗮 𝗽𝗿𝗼𝘀𝗽𝗲𝗿𝗼𝘂𝘀, 𝗵𝗲𝗮𝗹𝘁𝗵𝘆, 𝗮𝗻𝗱 𝗵𝗮𝗽𝗽𝘆 𝗡𝗲𝘄 𝗬𝗲𝗮𝗿! #HappyNewYear #Gratitude #NewYear2025

  • 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗧𝗿𝗶𝗮𝗹𝘀 𝘁𝗼 𝗹𝗼𝗼𝗸 𝗼𝘂𝘁 𝗳𝗼𝗿 𝗶𝗻 𝟮𝟬𝟮𝟱 👀 Clinical research in 𝟮𝟬𝟮𝟰 has brought forth transformative treatments, expanding the possibilities of modern medicine.   As we approach 𝟮𝟬𝟮𝟱, several promising therapies are on the horizon. These trials aim to improve treatment outcomes, prevent diseases, and tackle global health challenges. The results can be expected to transform the healthcare landscape in the coming years.   Here are some interesting treatments to look forward to.   Let us know what sparks your enthusiasm the most!  Expecto Health Science Ionis Pharmaceuticals, Inc. Beam Therapeutics University of Oxford Jazz Pharmaceuticals NYU Langone Health University of Nairobi Stanford University

  • As the holiday season approaches, we want to take a moment to extend our heartfelt thanks to all our colleagues, clients and partners for their continued trust and support. It’s been a pleasure working together, and we truly appreciate the opportunity to contribute to your success. We wish you all a joyful and restful holiday season, filled with happiness and warmth. We look forward to even more fruitful collaborations in the coming year. Happy Holidays from the Expecto Health Science Team!

    • No alternative text description for this image
  • 𝗧𝗵𝗲 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝘁𝗿𝗶𝗮𝗹𝘀 𝗹𝗮𝗻𝗱𝘀𝗰𝗮𝗽𝗲 𝗶𝗻 𝟮𝟬𝟮𝟰 𝗵𝗮𝘀 𝗯𝗲𝗲𝗻 𝘀𝗶𝗴𝗻𝗶𝗳𝗶𝗰𝗮𝗻𝘁𝗹𝘆 𝘀𝗵𝗮𝗽𝗲𝗱 𝗯𝘆 𝘁𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝗶𝗰𝗮𝗹 𝗮𝗱𝘃𝗮𝗻𝗰𝗲𝗺𝗲𝗻𝘁𝘀. We've seen a surge in the adoption of decentralized trials (DCTs), AI-powered data analysis, and wearable tech for remote monitoring. These innovations are increasing efficiency, reducing costs, and improving patient engagement. 𝗧𝗵𝗶𝘀 𝘆𝗲𝗮𝗿 𝗵𝗮𝘀 𝗺𝗮𝗿𝗸𝗲𝗱 𝗮 𝘁𝘂𝗿𝗻𝗶𝗻𝗴 𝗽𝗼𝗶𝗻𝘁 𝗳𝗼𝗿 𝗽𝗮𝘁𝗶𝗲𝗻𝘁-𝗰𝗲𝗻𝘁𝗿𝗶𝗰𝗶𝘁𝘆 𝗶𝗻 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝘁𝗿𝗶𝗮𝗹𝘀. The industry is increasingly focused on making trials more accessible, convenient, and inclusive. This includes greater use of telehealth, remote data capture, and efforts to improve diversity in trial populations. 𝗘𝗳𝗳𝗶𝗰𝗶𝗲𝗻𝗰𝘆 𝗮𝗻𝗱 𝗱𝗮𝘁𝗮-𝗱𝗿𝗶𝘃𝗲𝗻 𝗱𝗲𝗰𝗶𝘀𝗶𝗼𝗻-𝗺𝗮𝗸𝗶𝗻𝗴 𝗵𝗮𝘃𝗲 𝗯𝗲𝗲𝗻 𝗸𝗲𝘆 𝘁𝗵𝗲𝗺𝗲𝘀 𝗶𝗻 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝘁𝗿𝗶𝗮𝗹𝘀 𝗶𝗻 𝟮𝟬𝟮𝟰. The industry is leveraging real-world evidence (RWE), AI, and machine learning to optimize trial design, accelerate recruitment, and improve data analysis. This is leading to faster timelines and more meaningful results. What trends are you most excited about? Share your comments below! #ClinicalTrials #Innovation #Healthcare #RWE #AI #DataScience #PatientCentricity #Diversity #Inclusion

  • Our Medical Director, Dr Apurva Gawai, had the pleasure of participating in the 4th Global Medical Affairs Conference (GMAC 2024) at D.Y. Patil University, School of Medicine. During the BIOSIMILARS: NAVIGATING REGULATORY, MARKET ACCESS, AND CLINICAL CHALLENGES GLOBALLY AND IN INDIA panel discussions, Dr Gawai and the panel delved into the complex issues surrounding biosimilars and their potential to improve access to affordable biologics, both globally and in India. Thank you RENOVARE Healthcare Solutions for making Expecto Health Science a part of this successful event which brought together academicians, researchers, and industry professionals for immersive learnings and networking. #biosimilars #regulatory #MarketAccess #Biotech #ClinicalResearch #MedicalAffairs

    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image

Similar pages